
We can close the elective surgery backlog, but it will require the healthcare industry to embrace new technologies and innovation.

Adjunct Professor of Economics at the NYU Stern School of Business, and the President and CEO of AposTherapy®, a global medical device company that combines science and innovation to give individuals seeking neuromuscular and musculoskeletal health the power of movement. To learn more about AposTherapy, visit: www.apostherapy.com.

Published: October 21st 2020 | Updated: